Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Sign Up to like & getrecommendations! Published in 2017 at "Enfermedades infecciosas y microbiologia clinica"
DOI: 10.1016/j.eimc.2016.06.013
Abstract: INTRODUCTION GESIDA and the AIDS National Plan panel of experts suggest preferred (PR), alternative (AR), and other regimens (OR) for antiretroviral treatment (ART) as initial therapy in HIV-infected patients for the year 2016. The objective… read more here.
Keywords: analysis; efficacy; aids national; cost efficacy ... See more keywords